Tsukasa Nozu, Saori Miyagishi, Masatomo Ishioh, Kaoru Takakusaki, & Toshikatsu Okumura. (2023). Imeglimin prevents visceral hypersensitivity and colonic hyperpermeability in irritable bowel syndrome rat model. Elsevier.
Chicago Style (17th ed.) CitationTsukasa Nozu, Saori Miyagishi, Masatomo Ishioh, Kaoru Takakusaki, and Toshikatsu Okumura. Imeglimin Prevents Visceral Hypersensitivity and Colonic Hyperpermeability in Irritable Bowel Syndrome Rat Model. Elsevier, 2023.
MLA (9th ed.) CitationTsukasa Nozu, et al. Imeglimin Prevents Visceral Hypersensitivity and Colonic Hyperpermeability in Irritable Bowel Syndrome Rat Model. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.